The lens was developed to provide cataract surgery patients with a full range of vision without glasses. The lenses were first introduced by J&J in 2019 and received FDA approval in May of this year.
David Shoemaker, MD, will be the first ophthalmologist in the U.S. to implant the lens. Dr. Shoemaker is the founder and director of laser cataract and lens replacement surgery at Sarasota-based Center For Sight. He is also the founder and CEO of US Eye.
US Eye operates 28 offices and three ambulatory surgery centers in Florida and South Carolina.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.